Acute decrease of cardio-ankle vascular index with the administration of beraprost sodium

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 5, 2012, Pages 479-484

  Takahashi, Mao ^a   Shiba, Tomoaki ^a   Hirano, Keiichi ^a   Hitsumoto, Takashi ^a   Shirai, Kohji ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Arterial stiffness parameter; Beraprost sodium; Cardio ankle vascular stiffness index; Stable prostacyclin analogue; Vasodilatory effects

Indexed keywords

BERAPROST; PROSTACYCLIN;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VOLUNTEER;

EID: 84861651588     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.9266     Document Type: Article

References (34)

1. Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ: Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010; 9: 167-176
2. Saito I, Konishi M, Iso H, Inoue M, Tsugane S: Impact of weight change on specific-cause mortality among middleaged Japanese individuals. J Epidemiol Community Health, 2009; 63: 447-454
3. Bramwell JC, Hill AV: Velocity of pulse wave in Man. Proc Roy Soc, 1922; B: 298-306
4. Paine RM: Pulse-wave velocity as an index of aging in the cardiovascular system. J Gerontol, 1948; 3: 303-305
5. Hallock P: Arterial elasticity in man in relation to age as evaluated by the pulse wave velocity method. Arch. Intern. 1934; 54: 770-798
6. Epstein EJ, Coulshed N: Assessment of aortic stenosis from the external carotid pulse wave. Br Heart J, 1964; 26: 84-96
7. Kraner JC, Ogden E, Mcpherson RC: Immediate variations in pulse wave velocity caused by adrenalin in short, uniform parts of the arterial tree. Am J Physiol, 1959; 197: 432-436
8. Simonson E, Nakagawa K: Effect of age on pulse wave velocity and "aortic ejection time" in healthy men and in men with coronary artery disease. Circulation, 1960; 22: 126-129
9. Tedgui AS, Levy BI, Sebag SR: Instantaneous blood flow, impedance and elastic properties computed in man from aortic pulse waves. J Theor Biol, 1983; 101: 345-354
10. Hasegawa M: Fundamental research on human aortic pulse wave velocity. Jikei Medical Journal, 1970: 85: 742-760
11. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio- ankle vascular index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
12. Nye ER: The effect of blood pressure alteration on pulse wave velocity. Bri Heart J, 1964; 266: 261-265
13. Hayashi K, Sato M, Niimi H, Handa H, Moritake K: Analysis of the constitutive laws of the vascular wall by finite deformation theory. Iyodenshi To Seitai Kogaku, 1975; 13: 293-297
14. Takenaka T, Hoshi H, Kato N, Kobayashi K, Takane H, Shoda J, Suzuki H: Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseases. J Atheroscler Thromb, 2008; 15: 339-344
15. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72:598-604
16. Kubozono T, Miyata M, Ueyama K, Nagaki A, Hamasaki S, Kusano K, Kubozono O, Tei C: Association between arterial stiffness and estimated glomerular filtration rate in the Japanese general population. J Atheroscler Thromb, 2009; 16: 840-845
17. Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, Suzuki M, Hirano K, Sugiyama Y, Tomaru T, Miyashita Y, Shirai K, Noike H: Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb, 2009; 16: 371-379
18. Kim KJ, Lee BW, Kim HM, Shin JY, Kang ES, Cha BS, Lee EJ, Lim SK, Lee HC: Associations between cardioankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb, 2011; 18: 328-336
19. Sakane K, Miyoshi T, Doi M, Hirohata S, Kaji Y, Kamikawa S, Ogawa H, Hatanaka K, Kitawaki T, Kusachi S, Yamamoto K: Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J Atheroscler Thromb, 2008; 15: 261-268
20. Ichihara A, Yamashita N, Takemitsu T, Kaneshiro Y, Sakoda M, Kurauchi-Mito A, Itoh H: Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. Am J Kidney Dis, 2008; 52: 947-955
21. Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral beraprost sodium, a prostaglandin I2 analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation, 2000; 102: 426-431
22. Tomiyama H, Arai T, Hirose K, Koji Y, Motobe K, Yambe M, Yamashina A: Effects of acute administration of beraprost sodium on parameters related to atherosclerotic vascular damage in coronary artery disease. J Cardiol, 2004; 43: 53-58
23. Ohata S, Ishibashi Y, Shimada T, Takahashi N, Sugamori T, Sakane T, Hirano Y, Oyake N, Murakami Y, Higami T: Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease. Clin Exp Pharmaco Physiol, 2006; 33: 381-387
24. Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med, 2001; 344: 1608-1621
25. Hardy P, Abran D, Hou X, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chemtob S: A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res, 1998; 83: 721-729
26. Kazuo Niwano, Masashi Arai, Koichi Tomaru, Tsuyoshi Uchiyama, Yoshio Ohyama Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M: Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMPresponsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res, 2003; 93: 523-530
27. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature, 1987; 327: 524-526
28. Murata K, Motayama T, Kotake C: Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis, 1986; 60: 251-262
29. Cherchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, Tira ME, De Luca G: Structual and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix,1990; 10: 362-372
30. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993; 29; 362: 801-809
31. Metaka F, Niu H: Biophysical Effects of Adrenaline on the Smooth Muscle of the Rabbit Common Carotid Artery. J Gen Physiol, 1972; 59: 92-102
32. Dzau VJ, Re R: Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation, 1994; 89: 493-498
33. Lam YW, Giard MJ, Warren JB: Calcium channel blockers and treatment of hypertension. Drug Intell Clin Pharm, 1986; 20: 187-198
34. Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M: Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells; close link between PGI2 signal and NO pathways. Circ Res, 2003; 93: 523-530